Form 4 for WST West Pharmaceutical Services
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0001127602-25-006118 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-20 | 2025-02-18 | WST | Winters Chad | VP, CAO | M - OptEx | $211.00 | +82.05 | 1,391 | +6% | +$17.3K |
| D | 2025-02-20 | 2025-02-18 | WST | Winters Chad | VP, CAO | F - Tax | $211.00 | -27.73 | 1,363 | -2% | -$5,851 |
| DM | 2025-02-20 | 2025-02-18 | WST | Winters Chad | VP, CAO | A - Grant | $0.00 | +1,178 | 356 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | M | A | 82.05 | $211.00 | 1,390.75 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-18 | F | D | 27.73 | $211.00 | 1,363.03 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-02-18 | A | A | 822 | $0.00 | 822 | D | $211.00 · 2026-02-18 to 2035-02-18 | 822 Common Stock | (F1) This award vests in four equal installments beginning on February 18, 2026. |
| 4 | Derivative | Rst. Stock Unit | 2025-02-18 | A | A | 356 | $0.00 | 356 | D | $0.00 · — to — | 356 Common Stock | (F1) This award vests in four equal installments beginning on February 18, 2026. |